Multiomics in Precision Medicine

To register Click Here

June 22-23, 2022 – The Broad Institute, Boston, MA

Emerging Strategies for Multiomics in Precision Medicine

Please join us for the most dynamic event of its kind attracting scientific researchers, clinical scientists and practitioners, and executives from companies around the world.

Multiomics in Precision Medicine will be held on June 22-23, 2022, at the Broad Institute in Boston, MA. Sessions will focus on the theme, Emerging Strategies for Multiomics in Precision Medicine.

Two key drivers in precision medicine have been the recognition that populations within a disease area need medicines tailored to their specific needs, and the ability to identify these populations by analyzing large, diverse datasets. Genomics has been extremely successful in identifying these populations and in characterizing the molecular mechanisms underlying disease, but genomics alone is not sufficient to inform effective precision medicine strategies.

Recent advances in multiomic approaches — including genomics, transcriptomics, epigenomics, proteomics, and metabolomics — enable a more comprehensive picture of disease biology. This promises to accelerate the development of precision medicine, but also presents challenges for researchers, clinicians, and health systems struggling to integrate disparate data sources into a cohesive clinical strategy.

Multiomics in Precision Medicine provides you with the latest opportunities, trends, and strategies from experts who are successfully implementing a range of omics approaches to advance molecularly informed medicine.

Multiomics in Precision Medicine brings you live, in-person sessions full of valuable insights from leaders in biotech, pharmaceuticals, diagnostics, clinical research, healthcare, and regulatory bodies. Please join us to network, engage, and discuss key challenges and opportunities with other attendees and thought leaders as we explore Emerging Strategies for Multiomics in Precision Medicine.

Two key drivers in precision medicine have been the recognition that populations within a disease area need medicines tailored to their specific needs and that these populations can be identified by analyzing large, diverse datasets. Genomics has been extremely successful in identifying these populations by categorizing disease conditions based on gene signatures.  And while genomics is necessary for many such categorizations, it was realized that genomics alone was not sufficient (and sometimes not applicable).  Researchers took the tack of using the general methods developed in genomics to discover fingerprints or signatures with other biomarkers to differentiate populations for a disease state.  Many such assays were already available, but precision medicine provided the impetus to create large-scale assay formats and analytical tools to categorize populations for treatments – this has been an important and critical differentiator for the growth of precision medicine.

Early Bird Rates through May 15, 2022

General Attendee:                                                    $580                 (after May 16 – $725)

Academic/Government/Non Profit:                 $500                (after May 16 – $625)

Resident/Student:                                                    $340                (after May 16 – $480)

Who should attend:

  • Clinicians, pathologists, histologists, diagnostics developers, AI and system software designers, payers, research scientists, or in regulatory affairs
  • Executives and Decision Makers – CEOs, CFOs, CTOs, CMOs, and CSOs
  • Payers and Insurers
  • Medical and Pharmacy Directors
  • Employer and Retiree Benefits Analysts
  • Research, Development, and Practicing Clinicians
  • Diagnostics Developers
  • Diagnostics Licensing, Sales, and Planning
  • Regulatory Leaders in Government and Business Affairs groups
  • Economic Planners and Forecasters
  • Marketing Leaders
  • Systems Developers for Systems and Software
  • Artificial and Augmented Intelligence Developers
  • Emerging ‘Omics Diagnostics in Genetics/Genomics, Proteomics/Protein-based Assays
  • Imaging label developers
  • Biomarker Research Scientists and Developers
  • Imaging platforms
  • Artificial/Augmented Intelligence, Informatics, Analytics, Signal and Image Processing